Reports on our company

Worth reading

29Immaterial

0–100. This measures how worthwhile something is to read, not how good or bad the company is.

Direction

Neutral

Direction inferred from the company’s description.

Scale

—

Displayed only when the document provides numerical figures.

Wording

Avoiding a definitive answer

How definitive the wording is.

Subject Entity

Sumitomo Pharma Co.,Ltd. and the Group

Occurrence3 August 2026 (date the report was published)

This disclosure08/04/2026

Cause

The report is based on the author’s own views and assertions

Impact on Earnings Forecast

The report makes no reference to the earnings forecast. Regarding the financial statements and other documents, the Company stated: “As of the present time, we do not plan to amend the financial statements and other documents we have published.”

Company response

Investigation structure

The Company has undergone audits by its accounting auditor pursuant to the Financial Instruments and Exchange Act and the Companies Act and has received an unqualified audit opinion.

Outlook

The Company will continue striving to provide timely and appropriate information disclosures.

Event that occurred
Item	Details
Event name	Reports on our company
Date of occurrence	3 August 2026 (date the report was published)
Subject Entity	Sumitomo Pharma Co.,Ltd. and the Group
Cause	The report is based on the author’s own views and assertions
Impact on Earnings Forecast	The report makes no reference to the earnings forecast. Regarding the financial statements and other documents, the Company stated: “As of the present time, we do not plan to amend the financial statements and other documents we have published.”
Investigation structure	The Company has undergone audits by its accounting auditor pursuant to the Financial Instruments and Exchange Act and the Companies Act and has received an unqualified audit opinion.
Outlook	The Company will continue striving to provide timely and appropriate information disclosures.

Items this document does not state (18)

Date recognized / date notice receivedTarget Locations / ProductsAmount of Impact on Business PerformanceAccounting period in which recognizedType of litigation or proceedingCourt or authorityPlaintiffDefendantDate of filing / date of actionClaim amount / surcharge amountAmount of receivables at risk of non-collection or delayed collectionSuspended operationsScheduled resumption dateMeasures to prevent recurrenceDirectors' and officers' liabilityVoting rights ownership percentage before the changeVoting rights ownership percentage after the changePlanned follow-up disclosure

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The report is based on the author’s own views and assertions, while the Company prepares and discloses its financial statements and other documents in accordance with applicable laws and accounting standards and has received an unqualified audit opinion from its accounting auditor.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.

Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.

Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.